Chronic hepatitis B affects between 800,000 and two million people in the United States and causes 4,000 deaths each year. Yet the costs and benefits of treatment have not been fully evaluated. Using a model that simulates disease progression, we compare treatment programs for hepatitis B that start...
Research Assistant
AI chat, annotations, notes & similar papers
No comments yet
Be the first to share your thoughts!